In cancer, the main anti-tumor immune responses are mediated by the tumor antigen recognizing CD8+ T cells after their activation and differentiation into effector cytotoxic T lymphocytes (CTLs) by APCs and CD4+ T cells [182]. Here, CD8A is linked to neoplasm.